What Applied Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 1 |
| Total trades | 0 | 20 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 2,525,000 |
| Disposed | 0 | 6,028,561 |
| Net activity | +0 | −3,503,561 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Chinoporos Constantine | See Remarks | Feb 03 | Tender Offer · U | −57,111 | — | — | 0 |
| Chinoporos Constantine | See Remarks | Feb 03 | Disposition to Issuer · D | −1,000,000 | — | — | 57,111 |
| Funtleyder Leslie D. | Chief Financial Officer | Feb 03 | Tender Offer · U | −152,959 | — | — | 0 |
| Funtleyder Leslie D. | Chief Financial Officer | Feb 03 | Disposition to Issuer · D | −2,375,000 | — | — | 152,959 |
| Lerner Teena | Director | Feb 03 | Tender Offer · U | −82,922 | — | — | 0 |
| Lerner Teena | Director | Feb 03 | Disposition to Issuer · D | −22,500 | — | — | 82,922 |
| Bailey Evan Prescott | Chief Medical Officer | Feb 03 | Tender Offer · U | −60,901 | — | — | 0 |
| Bailey Evan Prescott | Chief Medical Officer | Feb 03 | Disposition to Issuer · D | −1,235,915 | — | — | 60,901 |
| Skyler Jay S | Director | Feb 03 | Tender Offer · U | −42,500 | — | — | 0 |
| Skyler Jay S | Director | Feb 03 | Disposition to Issuer · D | −22,500 | — | — | 42,500 |
| Hooks Corwin Dale | Chief Commercial Officer | Feb 03 | Tender Offer · U | −5,753 | — | — | 0 |
| Hooks Corwin Dale | Chief Commercial Officer | Feb 03 | Disposition to Issuer · D | −862,500 | — | — | 5,753 |
| Kanter Stacy J. | Director | Feb 03 | Tender Offer · U | −42,500 | — | — | 0 |
| Kanter Stacy J. | Director | Feb 03 | Disposition to Issuer · D | −22,500 | — | — | 42,500 |
| Funtleyder Leslie D. | Chief Financial Officer | Jan 01 | Grant / award · A | +150,000 | — | — | 1,340,459 |
| Chinoporos Constantine | See Remarks | Dec 19 | Grant / award · A | +437,500 | — | — | 1,057,111 |
| Funtleyder Leslie D. | Chief Financial Officer | Dec 19 | Grant / award · A | +1,187,500 | — | — | 2,527,959 |
| Bailey Evan Prescott | Chief Medical Officer | Dec 19 | Grant / award · A | +437,500 | — | — | 1,296,816 |
| Hooks Corwin Dale | Chief Commercial Officer | Dec 19 | Grant / award · A | +312,500 | — | — | 868,253 |
| Kanter Stacy J. | Director | Dec 16 | Open-market sale · S | −43,000 | $0.11 | −$4.82K | 65,000 |
Loading...
